Digital Innovation in Pharma: What Will 2026 Bring?
This year will be the turning point from AI “hype” to the adoption of meaningful AI and digital health solutions in pharma. Here four predictions.
Naomi Fried, Ph.D.</a>, is the founder and CEO of <a href=https://medcitynews.com/author/nfried/"https://www.pharmstars.com/">PharmStars, the pharma-focused accelerator for digital health startups and a GP at PharmStars Ventures. Startups with digital innovations for pharma can apply to PharmStars’ Spring cohort until January 25, 2026. Previously, Naomi was VP of Innovation at Biogen, Chief Innovation Officer at Boston Children’s Hospital, and VP of Innovation & Advanced Technology at Kaiser Permanente." />
This year will be the turning point from AI “hype” to the adoption of meaningful AI and digital health solutions in pharma. Here four predictions.
The clinical trial process is complex, long, and always arduous. But the results of the drug development process can be amazing, new, safe, effective, life-changing, and life-enhancing therapies.
How to turn analytics into actual policy outcomes.
Solving three major challenges in the development of new oncology drugs